Reply of the authors to the letter by S.Ya. Braude and A.V. Men'

被引：0
|
作者：
Alimov, V.A.
Rakhlin, A.V.
机构：
来源：
Izvestiya Vysshikh Uchebnykh Zavedenij. Radiofizika | 2000年 / 43卷 / 09期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
No abstract available
引用
收藏
页码：837 / 839
相关论文
共 50 条
  • [31] Letter: biologic therapies are effective for prevention of post-operative Crohn's disease recurrence - authors' reply
    Jones, G. R.
    Kennedy, N. A.
    Lees, C. W.
    Arnott, I. D.
    Satsangi, J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (03) : 323 - 323
  • [32] Letter: biologics are effective in neutralising the detrimental effect of smoking on the natural course of Crohn's disease - authors' reply
    To, N.
    Gracie, D. J.
    Ford, A. C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (11) : 1246 - 1246
  • [33] Letter: mucosal healing is associated with improved long-term outcomes in Crohn's disease - authors' reply
    Shah, S. C.
    Colombel, J. -F.
    Sands, B. E.
    Narula, N.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (12) : 1347 - 1348
  • [34] Authors Reply Counterargument to the editor's letter about the article "Evaluation of functional disability after Chikungunya infection"
    Panato, Cristiane Silvia
    Figueredo, Eduardo Durans
    Bassi, Daniela
    Almeida Felipe da Silva, Ilana Mirian
    Araujo Firmo, Wellyson da Cunha
    Rego, Adriana Sousa
    Araujo Mendonca Silva, Flor de Maria
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2020, 53
  • [35] An open letter by the members of the Russian Psychological Society and the Russian Institute for Psychology to the President of the Russian Federation V.V. Putin calling for an urgent investigation of the circumstances of A.V. Brushlinskii's murder
    不详
    VOPROSY FILOSOFII, 2002, (04) : 184 - 185
  • [36] Letter: ustekinumab's effectiveness compared with vedolizumab in Crohn's disease-what about mucosal healing and biomarkers? Authors' reply
    Biemans, Vince B. C.
    Hoentjen, Frank
    Pierik, Marieke J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (04) : 753 - 754
  • [37] Authors Reply to Letter to the Editor- In Response to: Comment on Durrani et al.'s "Adalimumab for Ocular Inflammation"
    Durrani, Khayyam
    Kempen, John H.
    Foster, C. Stephen
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2019, 27 (01) : 71 - 71
  • [38] Letter: mucosal response in discriminating intestinal tuberculosis from Crohn's disease-when to look for it? Authors' reply
    Mouli, V. Pratap
    Kedia, S.
    Ahuja, V.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (06) : 860 - 861
  • [39] Authors' Reply to Letter to the Editor From Dr. Bliwise (re: "Sleep Architecture and Mental Health Among Community-dwelling Older Men")
    Smagula, Stephen F.
    Stone, Katie L.
    Redline, Susan
    Cauley, Jane A.
    JOURNALS OF GERONTOLOGY SERIES B-PSYCHOLOGICAL SCIENCES AND SOCIAL SCIENCES, 2016, 71 (03): : 485 - 487
  • [40] Letter: should HCV cirrhotics with high bilirubin or Gilbert's syndrome be excluded from paritaprevir, ombitasvir, or dasabuvir? Authors' reply
    Banerjee, D.
    Reddy, K. R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (09) : 1022 - 1023
12345